Toripalimab
FDA Delay Coherus’ Approvals for PD-1 Inhibitor and Neulasta Biosimilar Injector
Anika Sharma
Coherus BioSciences has experienced a challenging journey in seeking FDA approval for its PD-1 inhibitor, toripalimab, developed in partnership with ...
ASCO 2023: Unlocking the Potential of TGF-β Inhibition
SG Tylor
ABSTRACT NUMBER: 6026 Recent studies have underscored the crucial role of the TGF-β signalling pathway in shaping the immune microenvironment ...
